Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Visual criteria in small bowel tumors detected by capsule endoscopy - morphological description and correlations with histological type.

Singeap AM, Trifan A, Sfarti C, Chiriac Ş, Huiban L, Stanciu C, Danciu M.

Rom J Morphol Embryol. 2019;60(1):159-165.

2.

Duodenoscope-Associated Infections beyond the Elevator Channel: Alternative Causes for Difficult Reprocessing.

Balan GG, Rosca I, Ursu EL, Fifere A, Varganici CD, Doroftei F, Turin-Moleavin IA, Sandru V, Constantinescu G, Timofte D, Stefanescu G, Trifan A, Sfarti CV.

Molecules. 2019 Jun 25;24(12). pii: E2343. doi: 10.3390/molecules24122343.

3.

Malnutrition Prevalence in Newly Diagnosed Patients with Inflammatory Bowel Disease - Data from the National Romanian Database.

Ciocîrlan M, Ciocîrlan M, Iacob R, Tanțău A, Gheorghe L, Gheorghe C, Dobru D, Constantinescu G, Cijevschi C, Trifan A, Goldiș A, Diculescu M.

J Gastrointestin Liver Dis. 2019 Jun 1;28:163-168. doi: 10.15403/jgld-176.

4.

Efficacy and safety of alisporivir for the treatment of hepatitis C infection.

Stanciu C, Trifan A, Muzica C, Sfarti C.

Expert Opin Pharmacother. 2019 Mar;20(4):379-384. doi: 10.1080/14656566.2018.1560424. Epub 2018 Dec 21. Review.

PMID:
30576256
5.

Diagnosis and Treatment of Colonic Diverticular Disease: Position Paper of the Romanian Society of Gastroenterology and Hepatology.

Trifan A, Gheorghe C, Marica Sabo C, Diculescu M, Nedelcu L, Singeap AM, Sfarti C, Gheorghe L, Sporea I, Tanțău M, Scripcariu V, Goldiș A, Gheonea D, Manuc M, Stanciu C, Scarpignato C, Dumitrascu DD.

J Gastrointestin Liver Dis. 2018 Dec;27(4):449-457. doi: 10.15403/jgld.2014.1121.274.rom.

6.

Nonalcoholic Fatty Liver Disease: Status Quo.

Sporea I, Popescu A, Dumitrașcu D, Brisc C, Nedelcu L, Trifan A, Gheorghe L, Fierbințeanu Braticevici C.

J Gastrointestin Liver Dis. 2018 Dec;27(4):439-448. doi: 10.15403/jgld.2014.1121.274.quo. Review.

7.

A half century of endoscopic retrograde colangiopancreatography: reflections of the past, present and future.

Stanciu C, Sfarti C, Chiriac S, Balan GG, Trifan A.

J Gastrointestin Liver Dis. 2018 Dec;27(4):357-360. doi: 10.15403/jgld.2014.1121.274.aha. No abstract available.

8.

Splanchnic Vein Thrombosis in Cirrhosis - Areas Still in the Shadow.

Gîrleanu I, Trifan A, Sfarti C.

Clin Transl Gastroenterol. 2018 Dec 7;9(12):211. doi: 10.1038/s41424-018-0079-3. No abstract available.

9.

Endoscopic retrograde cholangiopancreatography (ERCP) in patients with periampullary diverticula.

Sfarti VC, Bălan G Jr, Chiriac AŞ, Stanciu C, Bălan G, Gafencu-Şavlovschi D, Trifan AV.

Rom J Morphol Embryol. 2018;59(3):833-837.

10.

Helicobacter pylori prevalence and risk factors among children with celiac disease.

Maxim R, Pleşa A, Stanciu C, Girleanu I, Moraru E, Trifan A.

Turk J Gastroenterol. 2019 Mar;30(3):284-289. doi: 10.5152/tjg.2018.18181.

11.

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.

Gîrleanu I, Trifan A, Stanciu C, Sfarti C.

World J Gastroenterol. 2018 Oct 21;24(39):4419-4427. doi: 10.3748/wjg.v24.i39.4419.

12.

Gastrointestinal endoscopy in patients on direct oral anticoagulants. A consensus paper of the Romanian Society of Gastroenterology and Hepatology.

Farcas A, Bataga S, Cijevschi C, Diculescu M, Dobru D, Dumitru E, Goldis A, Nedelcu L, Popescu A, Sporea I, Trifan A, Valean S, Gheorghe C, Dumitrascu DL.

J Gastrointestin Liver Dis. 2018 Jun;27(2):179-187. doi: 10.15403/jgld.2014.1121.272.end.

13.

Plasma-activated water: a new and effective alternative for duodenoscope reprocessing.

Bălan GG, Roşca I, Ursu EL, Doroftei F, Bostănaru AC, Hnatiuc E, Năstasă V, Şandru V, Ştefănescu G, Trifan A, Mareş M.

Infect Drug Resist. 2018 May 17;11:727-733. doi: 10.2147/IDR.S159243. eCollection 2018.

14.

Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older.

Trifan A, Stanciu C, Gheorghe L, Iacob S, Curescu M, Cijevschi Prelipcean C, Stefanescu G, Girleanu I, Chiriac S, Mihai C, Brisc C, Goldis A, Sporea I, Miftode E, Bataga S, Rogoveanu I, Preda C, Caruntu FA, Singeap AM.

Medicine (Baltimore). 2017 Dec;96(50):e9271. doi: 10.1097/MD.0000000000009271.

15.

New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania.

Manuc M, Preda CM, Popescu CP, Baicuș C, Voiosu T, Pop CS, Gheorghe L, Sporea I, Trifan A, Tanțău M, Tanțău A, Ceaușu E, Proca D, Constantinescu I, Ruta SM, Fulger LE, Diculescu M, Oproiu A.

J Gastrointestin Liver Dis. 2017 Dec;26(4):381-386. doi: 10.15403/jgld.2014.1121.264.cvr.

16.

Clostridium difficile infection in hospitalized octogenarian patients.

Trifan A, Girleanu I, Stanciu C, Miftode E, Cojocariu C, Singeap AM, Sfarti C, Chiriac S, Cuciureanu T, Stoica O.

Geriatr Gerontol Int. 2018 Feb;18(2):315-320. doi: 10.1111/ggi.13186. Epub 2017 Nov 15.

PMID:
29139189
17.

Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.

Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, Chiriac SA, Ciobica A, Boiculese L.

World J Gastroenterol. 2017 Sep 21;23(35):6500-6515. doi: 10.3748/wjg.v23.i35.6500. Review.

18.

Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two.

Gheorghe L, Sporea I, Iacob S, Sirli R, Trifan A, Diculescu M, Stanciu C, Pascu O, Acalovschi M, Brisc C, Cijevschi C, Gheorghe C, Spârchez Z, Rogoveanu I, Dobru D, Dumitrascu DL.

J Gastrointestin Liver Dis. 2017 Sep;26(3):309-317. doi: 10.15403/jgld.2014.1121.263.rom. Review.

19.

Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis.

Gheorghe L, Iacob S, Curescu M, Brisc C, Cijevschi C, Caruntu F, Stanciu C, Simionov I, Sporea I, Gheorghe C, Iacob R, Arama V, Sirli R, Trifan A.

J Gastrointestin Liver Dis. 2017 Sep;26(3):275-281. doi: 10.15403/jgld.2014.1121.263.iac.

20.

Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

Preda CM, Popescu CP, Baicus C, Voiosu TA, Manuc M, Pop CS, Gheorghe L, Sporea I, Trifan A, Tantau M, Tantau A, Ceausu E, Proca D, Constantinescu I, Ruta SM, Diculescu MM, Oproiu A.

Liver Int. 2018 Apr;38(4):602-610. doi: 10.1111/liv.13550. Epub 2017 Sep 5.

PMID:
28816020

Supplemental Content

Loading ...
Support Center